There are 2789 resources available
Current landscape: Did we learn how to select first-line strategy?
Presenter: Edward Garon
Session: Refining the use of immune-checkpoint inhibition
Resources:
Slides
Webcast
Mechanisms of resistance and novel strategies
Presenter: Céline Mascaux
Session: Refining the use of immune-checkpoint inhibition
Resources:
Abstract
Slides
Webcast
Do we have any idea how to use these drugs in oncogene addicted patients yet?
Presenter: Julien Mazieres
Session: Refining the use of immune-checkpoint inhibition
Resources:
Slides
Webcast
Immunotherapy and the heart: What could possibly go wrong?
Presenter: Bettina Heidecker
Session: Know your immunotherapy and its toxicities
Resources:
Slides
Webcast
Immunotherapy induced neurotoxicity: Current understanding
Presenter: Matthias Preusser
Session: Know your immunotherapy and its toxicities
Resources:
Slides
Webcast
What else does immunotherapy do?
Presenter: John Haanen
Session: Know your immunotherapy and its toxicities
Resources:
Slides
Webcast
Introduction
Presenter: Martijn Lolkema
Session: Impact of lineage plasticity and heterogeneity on cancer therapies
Resources:
Webcast
Role of lineage plasticity in response and resistance to therapies
Presenter: Himisha Beltran
Session: Impact of lineage plasticity and heterogeneity on cancer therapies
Resources:
Slides
Webcast
Recapitulating human cancer through organoid models: Therapeutic implications of cellular heterogeneity
Presenter: Jeanine Roodhart
Session: Impact of lineage plasticity and heterogeneity on cancer therapies
Resources:
Slides
Webcast
How representative mouse models can provide insights to therapeutic vulnerabilities
Presenter: Katerina Politi
Session: Impact of lineage plasticity and heterogeneity on cancer therapies
Resources:
Slides
Webcast